Medical Cannabis and Cancer: A UK Patient’s Guide to Access, Evidence, and What Actually Helps

First things first, in the age of disclaimers, I need to be upfront: I’m not a doctor. I’m a Stage IV cancer patient who reads research, asks questions, and shares what I learn. Everything here is my experience and my interpretation of the evidence. Talk to your oncologist before changing anything about your treatment.

With that said, let’s talk about Cannabis… Weed… Sweet MaryJane… or, whatever you choose to call it…

Medical cannabis has been legal in the UK since November 2018, but you wouldn’t know it from the way most cancer patients are left in the dark. The information out there is either written by cannabis clinics trying to sell you a prescription, charities being cautiously vague, or forums full of unverified claims about Rick Simpson Oil (RSO) curing everything. None of that helps when you’re sitting in a chemo ward wondering whether cannabis could ease the nausea that won’t shift.

This article is what I wish someone had written for me when I first started looking into it. It covers the legal position, how to actually get a prescription, what it costs, what the evidence supports (and what it doesn’t), drug interactions your oncologist needs to know about, and what I personally use. Cannabis is one small part of my Stage IV protocol – alongside conventional treatment, repurposed drugs, and other integrative approaches.

---

Is Medical Cannabis Legal in the UK?

Yes. Since 1 November 2018, cannabis-based products for medicinal use (CBMPs) have been reclassified from Schedule 1 to Schedule 2 under the Misuse of Drugs Regulations 2001. That means specialist doctors on the GMC Specialist Register can legally prescribe them.

Cannabis itself remains a Class B drug. You cannot legally possess, grow, or buy it without a prescription. But with a valid prescription from a specialist consultant, you can legally receive cannabis flower, oils, capsules, and other products.

Here’s the catch: the gap between “legal” and “accessible” is enormous.

On the NHS, medical cannabis is prescribed for only three conditions:

• Rare severe epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
• Chemotherapy-induced nausea and vomiting (nabilone only – a synthetic THC capsule)
• Multiple sclerosis spasticity (Sativex)

That’s it. NICE guideline NG144 explicitly says “do not offer” cannabis-based products for chronic pain. Even for the approved conditions, NHS prescriptions have been vanishingly rare.

The reality is that almost every UK patient accessing medical cannabis does so through private clinics. That includes me.

---

What Medical Cannabis Can (and Can’t) Do for Cancer Patients

Let me break this down honestly, symptom by symptom.

Nausea and Vomiting

This is the strongest evidence base. NICE NG144 recommends nabilone (synthetic THC) as an add-on treatment for chemo-induced nausea that persists despite standard antiemetics. A 2024 randomised controlled trial published in the Journal of Clinical Oncology found that CBD oil reduced nausea more effectively than placebo. A 2023 systematic review confirmed that cannabinoids improved nausea control when used alongside standard medications.

The mechanism makes sense too – cannabinoids interact with serotonin (5-HT1A) and TRPV1 receptors, both central to nausea signalling.

My take: If you’re struggling with chemo nausea and ondansetron isn’t cutting it, this is worth discussing with your oncologist. The evidence is solid.

Pain

The BMJ published a systematic review and meta-analysis in 2021 (BMJ 2021;374:n1034) covering 30+ trials. It found cannabis-based medicines produced small but consistent improvements in pain scores and sleep quality.

A study from the Quebec Cannabis Registry followed over 350 cancer patients for nine months. Pain scores dropped within roughly a week of starting cannabis treatment. Balanced THC:CBD products worked better than THC alone. Opioid use decreased.

NICE recommends against cannabis for chronic pain on the NHS – but that reflects cost-effectiveness thresholds, not an absence of evidence.

My take: The pain reduction isn’t dramatic for everyone, but for patients already on opioids who want to reduce their dose, the combination can be genuinely useful. I’ve written more about the full range of pain approaches I’ve tried – including some you won’t hear about from your GP – in surviving cancer pain and neuropathy.

Appetite Loss

Cachexia affects an estimated 82% of patients with advanced cancer. A 2024 review published in Cancers examined cannabinoids in cachexia care and found THC linked to appetite stimulation and, in some trials, modest weight gain. THC directly stimulates appetite via CB1 receptor activation. CBD doesn’t boost hunger directly but can ease nausea, making food more tolerable.

My take: If you’re struggling to eat, THC-containing products are worth exploring. This isn’t a miracle appetite fix, but it can take the edge off.

Sleep

The same BMJ meta-analysis found measurable improvements in sleep quality alongside pain reduction. CBD appears to reduce the anxiety that disrupts sleep, while low-dose THC can promote sleep onset. There’s also emerging research on CBN (cannabinol) and its sedative properties.

My take: Better sleep has been one of the more noticeable benefits for me. Not every night, but more good nights than before.

Anxiety

This is where it gets nuanced. CBD shows consistent anxiolytic effects through serotonin pathway interactions. But THC is a double-edged sword – low doses may help anxiety, while higher doses can genuinely worsen it. The BMJ meta-analysis described the impact on anxiety as “less clear” than for pain and sleep.

My take: If anxiety is your primary concern, start with CBD-dominant products. THC for anxiety requires very careful dose management.

Anti-Tumour Effects

I need to be straight with you here: there is no reliable evidence that cannabis treats cancer in humans.

Laboratory studies show cannabinoids can trigger cancer cell death, stop cancer cells dividing, inhibit blood vessel formation that tumours need, and slow metastatic spread – in petri dishes and mouse models. One small trial (21 patients) of THC:CBD combined with temozolomide for glioblastoma showed a trend toward improved survival, but it was far too small to be conclusive.

There’s a 2024 paper in Cancer Immunology Research showing CBD enhanced the immunotherapy drug atezolizumab in triple-negative breast cancer models, which is interesting.

But Macmillan Cancer Support flags something most cannabis advocates won’t tell you: cannabinoids have also been found to damage blood vessels, and in some situations can encourage cancer cell growth or suppress immune function.

The ASCO guideline from 2024 states plainly: clinicians should recommend against using cannabis as cancer-directed treatment unless within a clinical trial.

My take: I use cannabis for symptom management, not as a cancer treatment. The pre-clinical research is genuinely interesting, and I hope clinical trials eventually clarify things. But if someone tells you cannabis oil will cure your cancer, they are either misinformed or selling something. The same honest assessment applies to other off-label drugs being discussed in cancer communities – I’ve done a similar deep dive on ivermectin if you’re researching that too.

---

CBD vs THC – What’s the Difference and Why It Matters

Most people start with CBD because it’s available over the counter. But for cancer patients, the distinction matters:

	THC	CBD
Psychoactive?	Yes	No
UK legal status	Prescription only (Schedule 2)	Legal as supplement if <0.2% THC
Pain	Effective via CB1 receptor binding	Indirect – anti-inflammatory, modulates endocannabinoid system
Nausea	Strong anti-emetic (nabilone is synthetic THC)	2024 RCT shows benefit vs placebo
Appetite	Direct stimulation	No direct effect; reduces nausea making eating easier
Sleep	Promotes onset at low doses	Reduces anxiety that disrupts sleep
Anxiety	Low dose may help; high dose can worsen	Consistent anxiolytic effect
Side effects	Dizziness, confusion, dependency risk	Generally well tolerated; liver monitoring at high doses

The critical point: Over-the-counter CBD products are not the same as prescribed medical cannabis. Shop-bought CBD supplements are unregulated – a 2017 study found 21% of CBD products sold online contained undisclosed THC. The Food Standards Agency advises limiting CBD intake to 10mg per day. If you’re already taking supplements alongside your treatment, adding unregulated CBD on top creates interaction risks you can’t monitor.

If you want meaningful symptom relief, particularly for pain, nausea, and appetite, you almost certainly need THC – and that means a prescription.

There’s also the “entourage effect” – the theory that cannabinoids, terpenes, and other plant compounds work better together than in isolation. This is why many prescribers recommend full-spectrum products rather than isolated THC or CBD.

---

How to Get a Medical Cannabis Prescription in the UK

Here’s the step-by-step process. It’s simpler than most people expect.

Step 1: Check eligibility. You need a diagnosed condition that hasn’t responded adequately to at least two conventional treatments. Cancer patients seeking help with pain, nausea, appetite loss, sleep, or anxiety typically qualify. You do not need a GP referral.

Step 2: Choose a clinic. Most offer a free online eligibility checker that takes five to ten minutes. All consultations are typically conducted via video call – no travel required. See the clinic comparison below.

Step 3: Provide medical records. You’ll need your Summary Care Records or GP records. Some clinics can request these on your behalf with a signed consent form.

Step 4: Initial consultation. A video appointment with a specialist doctor, usually 20-30 minutes. They review your medical history, current medications, and treatment goals. If they decide medical cannabis isn’t appropriate, most clinics refund the consultation fee.

Step 5: Prescription issued. Products are tailored to your condition – balanced THC:CBD oil for pain, CBD-dominant for anxiety, and so on. Dosing follows a “start low, go slow” approach.

Step 6: Dispensing and delivery. Prescriptions are filled by a licensed pharmacy and delivered to your home. Typical turnaround is two to five working days.

Step 7: Ongoing monitoring. Follow-up appointments every one to three months initially, then quarterly once stable.

---

How Much Does Medical Cannabis Cost in the UK?

This is the question everyone asks and few articles answer honestly. Here’s a real breakdown.

Clinic Comparison

Clinic	Initial Consultation	Follow-up	Delivery	Notes
Curaleaf (formerly Sapphire)	GBP 30-50 per appointment	Included	Free	Largest UK clinic; CQC registered
Cantourage	GBP 99	GBP 29	GBP 7-11	German GMP-grade cannabis; veterans programme
Releaf	GBP 99.99	Free with Releaf+ (GBP 39.99/mo)	GBP 4.99 (free with Releaf+)	Dedicated oncology specialist
Integro	Free	GBP 49	Not specified	Free initial consultation
Zerenia	GBP 149	GBP 79-99	Not specified	Project Twenty21 partner
MEDCANN	GBP 200	GBP 95 quarterly	Not specified	GPhC registered pharmacy

Monthly Prescription Costs

• Cannabis flower (10g): GBP 50-150
• Cannabis oil (10ml): GBP 60-200
• Capsules (30 units): GBP 70-250

Realistic Monthly Totals

	Low	Mid	High
Monthly medication	GBP 150	GBP 300	GBP 800+
Consultations/subscriptions	GBP 5	GBP 30	GBP 80
Delivery	GBP 0	GBP 5	GBP 11
Monthly total	GBP 155	GBP 335	GBP 890+

How to Reduce Costs

Project Twenty21 is worth knowing about. Run by Drug Science (Professor David Nutt’s independent scientific body), it’s Europe’s largest medical cannabis patient registry. Patients get discounted medication – roughly GBP 7 per gram of flower versus GBP 10-15 standard – in exchange for allowing their treatment outcomes to be tracked via quarterly questionnaires. You can access it through participating clinics like Zerenia. Wide range of conditions accepted, including cancer symptoms.

---

Medical Cannabis and Driving in the UK

This comes up constantly and the information out there is confusing. Here’s the actual legal position (Having spent my pre-cancer years as a compliance professional, interpreting the law comes as second nature to me. Please however consult a qualified and practising legal professional if in any doubt).

The Drug Driving Act 2015 sets a THC blood limit of 2 micrograms per litre. This is extremely low – patients using THC-containing medical cannabis may exceed this even without feeling impaired.

However, Section 5A(3) of the Road Traffic Act 1988 provides a statutory medical defence. This applies if:

1. Your cannabis was legally prescribed by a specialist
2. You followed your prescriber’s instructions
3. You were not actually impaired while driving

This defence does not protect you if your driving is genuinely impaired.

Practical advice:

• Get a letter from your prescriber confirming your prescription
• Keep a copy in your car
• Inform your motor insurer in writing – failure to disclose could invalidate your cover
• Do not drive if you feel impaired, regardless of legality
• You do not need to notify the DVLA about your cannabis prescription specifically, but you must notify them if your underlying condition or medication effects impair your ability to drive

---

What About Cannabis Oil from the Internet?

I know people do this. And I understand why – it’s cheaper, there’s no waiting, and the claims about Rick Simpson Oil sound compelling when you’re desperate.

Rick Simpson Oil (RSO) is a concentrated cannabis extract, typically 60-90% THC, named after a Canadian who claims he cured his own skin cancer with it in 2003. He advocates consuming 60 grams over 90 days.

Here’s the reality:

• No clinical trials have ever been conducted on RSO specifically
• RSO is illegal in the UK – it contains high levels of THC and is not a prescribed medicine
• Unregulated production means unknown cannabinoid content, possible solvent residues, and contamination risk
• Very high THC doses carry risks including psychosis, severe anxiety, and dependency
• Drug interactions with chemotherapy are amplified by the high, uncontrolled THC content

I understand the impulse. But unregulated cannabis products are a gamble with your health at a time when you can least afford it. If you want high-THC treatment, private clinics can legally prescribe pharmaceutical-grade products with consistent dosing and proper quality control.

---

Drug Interactions Cancer Patients Need to Know About

This is the section I wish more cannabis articles included, because it genuinely matters.

Both THC and CBD are metabolised by, and inhibit, cytochrome P450 enzymes – the same enzyme family that processes most chemotherapy drugs. A 2021 study by Nasrin et al. (cited 185 times) found that major cannabinoid metabolites inhibit CYP2B6, CYP2C9, and CYP2D6.

Here’s what that means in practical terms:

Enzyme	Inhibited by	Chemotherapy drugs potentially affected
CYP3A4	CBD, THC	Cyclophosphamide, docetaxel, etoposide, irinotecan, paclitaxel, tamoxifen, vincristine
CYP2C9	THC metabolites	Cyclophosphamide, tamoxifen
CYP2C19	CBD	Cyclophosphamide
CYP2D6	CBD, THC metabolites	Tamoxifen, codeine, tramadol

The tamoxifen warning is critical. Tamoxifen requires CYP2D6 to convert to its active form, endoxifen. CBD inhibits CYP2D6. If you’re a breast cancer patient on tamoxifen and you’re using CBD – even over-the-counter CBD supplements – this interaction could theoretically reduce your tamoxifen’s effectiveness. Talk to your oncologist.

A 2024 paper in the British Journal of Clinical Pharmacology specifically examined CBD-drug interactions in cancer patients and concluded that monitoring is essential.

The bottom line: You must tell your oncologist if you’re using or considering any cannabis-based product. This isn’t about judgement – it’s about ensuring your cancer treatment works properly.

---

My Experience with Medical Cannabis

I want to share what I use and what I’ve noticed, with the caveat that my experience is one data point, not evidence.

I access medical cannabis through a private UK clinic – Curaleaf – via video consultation. My prescription includes both THC and CBD products, which I use primarily for pain management, nausea around treatment, appetite support, and sleep.

It fits into my broader protocol alongside conventional treatment, not instead of it. My oncologist knows. My integrative team at the National Centre for Integrative Medicine (NCIM) in Bristol knows. Nobody has an issue with it. If you want the full picture of how I approach pain and exhaustion during treatment, I wrote about that in fighting cancer pain and exhaustion.

What I’ve noticed:

• Nausea: Noticeably better on treatment days. Not eliminated, but the worst edges taken off.
• Sleep: More good nights than before. Not every night, but enough to make a difference.
• Appetite: Moderate improvement. I eat more consistently, though I wouldn’t call it dramatic.
• Pain: Helpful alongside other pain management, not a replacement for it. I also use cold therapy, infrared sauna sessions, and red light therapy as part of my pain and recovery routine – cannabis complements these rather than replacing them.
• What it doesn’t do: It hasn’t shrunk any tumours. I don’t use it for that purpose and I wouldn’t claim it does.

The cost is real – several hundred pounds a month. That’s a significant commitment and I understand it’s not accessible for everyone. Project Twenty21 can help reduce costs, and I’d encourage anyone exploring this route to look into it.

---

I’m not a doctor. I’m a cancer patient who reads research and asks questions. Everything here is my experience and my interpretation of the evidence. Medical cannabis is a tool for symptom management, not a cancer cure. Talk to your oncologist before changing anything about your treatment.

If you found this useful, sign up for The Life Organic newsletter – I share what I learn as I learn it.

Frequently Asked Questions